Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Greenspan

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Circulation|December 1, 1978
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimensL N Horowitz, M E Josephson, A Farshidi, et al.
The American Journal of Cardiology|May 1, 1988
Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery diseaseM D Meissner, H R Kay, L N Horowitz, et al.
Journal of the American College of Cardiology|August 1, 1985
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapyA P Rae, N M Sokoloff, C R Webb, et al.
The New England Journal of Medicine|January 21, 1988
Incidence of unwarranted implantation of permanent cardiac pacemakers in a large medical populationA M Greenspan, H R Kay, B C Berger, et al.
American Journal of Nephrology|January 1, 1986
Lethal accumulation of procainamide metabolite in severe renal insufficiencyP H Vlasses, R K Ferguson, M L Rocci, et al.
Acta Cytologica|July 1, 1985
Malignant islet-cell tumor of the pancreas diagnosed by fine needle aspiration biopsy. A case reportJ G Hsiu, N A D'Amato, M H Sperling, et al.
The American Journal of Cardiology|August 1, 1985
Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery diseaseA M Greenspan, S R Spielman, C R Webb, et al.
Clinical Pharmacology and Therapeutics|June 1, 1985
Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmiaL N Horowitz, A M Greenspan, S R Spielman, et al.
Journal of the American College of Cardiology|July 1, 1987
Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmiaT J Waller, H R Kay, S R Spielman, et al.
The American Journal of Cardiology|August 1, 1987
Determinants of hospital cost and length of stay for patients undergoing electrophysiologic testingH R Kay, L N Horowitz, H Goldstein, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Circulation|December 1, 1978
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimensL N Horowitz, M E Josephson, A Farshidi, et al.
The American Journal of Cardiology|May 1, 1988
Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery diseaseM D Meissner, H R Kay, L N Horowitz, et al.
Journal of the American College of Cardiology|August 1, 1985
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapyA P Rae, N M Sokoloff, C R Webb, et al.
The New England Journal of Medicine|January 21, 1988
Incidence of unwarranted implantation of permanent cardiac pacemakers in a large medical populationA M Greenspan, H R Kay, B C Berger, et al.
American Journal of Nephrology|January 1, 1986
Lethal accumulation of procainamide metabolite in severe renal insufficiencyP H Vlasses, R K Ferguson, M L Rocci, et al.
Acta Cytologica|July 1, 1985
Malignant islet-cell tumor of the pancreas diagnosed by fine needle aspiration biopsy. A case reportJ G Hsiu, N A D'Amato, M H Sperling, et al.
The American Journal of Cardiology|August 1, 1985
Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery diseaseA M Greenspan, S R Spielman, C R Webb, et al.
Clinical Pharmacology and Therapeutics|June 1, 1985
Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmiaL N Horowitz, A M Greenspan, S R Spielman, et al.
Journal of the American College of Cardiology|July 1, 1987
Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmiaT J Waller, H R Kay, S R Spielman, et al.
The American Journal of Cardiology|August 1, 1987
Determinants of hospital cost and length of stay for patients undergoing electrophysiologic testingH R Kay, L N Horowitz, H Goldstein, et al.
Pageof 15